Hyperammonemic encephalopathy in a patient receiving fluorouracil/oxaliplatin chemotherapy

Hyperammonemia is a rare adverse effect of 5‐fluorouracil (5‐FU) therapy, but can be very serious, even fatal. Physicians must be aware that hyperammonemic encephalopathy sometimes develops as an adverse event after 5‐FU therapy.

Salvato in:
Dettagli Bibliografici
Pubblicato in:Clin Case Rep
Autori principali: Ihoriya, Hiromi, Yamamoto, Hirotsugu, Yamada, Taihei, Tsukahara, Kohei, Inoue, Kanae, Yumoto, Tetsuya, Naito, Hiromichi, Nakao, Atsunori
Natura: Artigo
Lingua:Inglês
Pubblicazione: John Wiley and Sons Inc. 2018
Soggetti:
Case Reports
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5889268/
https://ncbi.nlm.nih.gov/pubmed/29636922
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ccr3.1422
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi